Labcorp
Labcorp, officially known as Laboratory Corporation of America Holdings, is a leading global life sciences company headquartered in Burlington, North Carolina. Founded in 1971, Labcorp has established itself as a key player in the healthcare industry, providing comprehensive laboratory services and diagnostic solutions across North America and beyond. Specialising in clinical laboratory services, drug development, and genomic testing, Labcorp offers a unique blend of innovative technologies and extensive expertise. The company is renowned for its commitment to improving health outcomes through advanced diagnostics and personalised medicine. With a strong market position, Labcorp has achieved numerous milestones, including the integration of cutting-edge genomic testing into routine clinical practice, solidifying its reputation as a pioneer in the field.
DitchCarbon Score
How does Labcorp's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Labcorp's score of 35 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Labcorp's reported carbon emissions
In 2023, Labcorp reported total greenhouse gas (GHG) emissions of approximately 332,000 tonnes CO2e. This figure includes about 182,000 tonnes CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and around 150,000 tonnes CO2e from Scope 2 emissions, related to the generation of purchased electricity, steam, heating, and cooling. The company also reported significant Scope 3 emissions, with approximately 625,000 tonnes CO2e from purchased goods and services, 241,000 tonnes CO2e from upstream transportation and distribution, and 93,000 tonnes CO2e from downstream transportation and distribution. Labcorp has set ambitious climate commitments, aiming to reduce absolute Scope 1 and 2 GHG emissions by 42% by 2030, using 2020 as the base year. Additionally, the company targets a 25% reduction in absolute Scope 3 emissions from purchased goods and services, upstream transportation, and downstream transportation within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. Overall, Labcorp's commitment to reducing its carbon footprint reflects a proactive approach to addressing climate change within the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|
| Scope 1 | 173,797,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 175,982,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 932,054,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Labcorp is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
